These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 10384111

  • 1. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R, Yoneda Y, Kuriyama M, Kubota T.
    J Immunol; 1999 Jul 01; 163(1):148-54. PubMed ID: 10384111
    [Abstract] [Full Text] [Related]

  • 2. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y, Tashiro-Yamaji J, Kubota T, Yoshida R.
    Microbiol Immunol; 2008 Jul 01; 52(7):349-56. PubMed ID: 18667033
    [Abstract] [Full Text] [Related]

  • 3. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
    Yoneda Y, Yoshida R.
    J Immunol; 1998 Jun 15; 160(12):6012-7. PubMed ID: 9637516
    [Abstract] [Full Text] [Related]

  • 4. Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant.
    Aruga A, Aruga E, Chang AE.
    Cancer Res; 1997 Aug 01; 57(15):3230-7. PubMed ID: 9242454
    [Abstract] [Full Text] [Related]

  • 5. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, Okumura K.
    Cell Immunol; 2001 Dec 15; 214(2):194-200. PubMed ID: 12088418
    [Abstract] [Full Text] [Related]

  • 6. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J, Hamuro J, Fukushima A, Ohteki T, Terai K, Iwakura Y, Yagita H, Kinoshita S.
    Invest Ophthalmol Vis Sci; 2009 May 15; 50(5):2139-46. PubMed ID: 19136699
    [Abstract] [Full Text] [Related]

  • 7. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection.
    Takikawa O, Habara-Ohkubo A, Yoshida R.
    J Immunol; 1990 Aug 15; 145(4):1246-50. PubMed ID: 2116480
    [Abstract] [Full Text] [Related]

  • 8. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
    Yoshida R, Sanchez-Bueno A, Yamamoto N, Einaga-Naito K.
    J Immunol; 1997 Jul 01; 159(1):15-21. PubMed ID: 9200433
    [Abstract] [Full Text] [Related]

  • 9. Tryptophan degradation in transplanted tumor cells undergoing rejection.
    Yoshida R, Park SW, Yasui H, Takikawa O.
    J Immunol; 1988 Oct 15; 141(8):2819-23. PubMed ID: 3262668
    [Abstract] [Full Text] [Related]

  • 10. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb 15; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 11. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM, Zarling JM.
    J Immunol; 1983 Aug 15; 131(2):1017-23. PubMed ID: 6223084
    [Abstract] [Full Text] [Related]

  • 12. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 Aug 15; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 13. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity.
    Yanagihara K, Seyama T, Watanabe Y.
    Nat Immun; 1994 Aug 15; 13(2-3):102-12. PubMed ID: 8173232
    [Abstract] [Full Text] [Related]

  • 14. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M, Zajícová A, Fric J, Holán V.
    Transpl Int; 2002 Mar 15; 15(2-3):108-16. PubMed ID: 11935167
    [Abstract] [Full Text] [Related]

  • 15. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA, Mentzer SJ, Maizel SE.
    Cancer Res; 1982 Feb 15; 42(2):397-404. PubMed ID: 7055792
    [Abstract] [Full Text] [Related]

  • 16. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V, Pindjáková J, Zajícová A, Krulová M, Zelezná B, Matousek P, Svoboda P.
    Xenotransplantation; 2005 May 15; 12(3):227-34. PubMed ID: 15807773
    [Abstract] [Full Text] [Related]

  • 17. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
    Yoshida R, Oku T, Takikawa O, Einaga-Naito K, Yoneda Y, Hirota R, Kubota T.
    Microbiol Immunol; 2000 May 15; 44(1):57-67. PubMed ID: 10711600
    [Abstract] [Full Text] [Related]

  • 18. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG, Garofalo AS, Travassos LR.
    Cytokines Cell Mol Ther; 2002 May 15; 7(3):107-16. PubMed ID: 12850810
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.